November 19, 2021

51: The State of Sleep Medicine

37 minutes

Welcome to the NeurologyLive® Mind Moments™ podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.

In this episode, we spoke with Karl Doghramji, MD, professor of psychiatry and human behavior; professor of neurology; and medical director, Jefferson Sleep Disorders Center, at the Vickie and Jack Farber Institute for Neuroscience of Jefferson Health. He shared his perspective on the current state of care for sleep disorders, the impact of the pandemic on sleep in the US, and some of the recent advances in therapeutics and research.

Episode Breakdown:

1:15 – The role of sleep in individuals' emotional and physical lives

5:40 – Current awareness about the health effects of poor sleep

8:15 – Clinical and commercial tools to measure sleep

10:45 – Recent advances in therapeutics for sleep disorders

15:20 – Tailoring specific therapies for specific patients

17:15 – Neurology News Minute

19:45 – Narcolepsy as a model for other sleep disorders

22:20 – Patient identification and differential diagnosis

25:40 – The sleep specialist's inclusion in the comprehensive care model

28:25 – Meeting the increasing demand for sleep specialists

30:40 – Sleep's role in dementia and cognition

33:50 – The state of sleep amid the COVID-19 pandemic

The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:

Phase 3 PHOENIX Study of AMX0035 in ALS Gets Under Way

FDA Approves First Oral Solution of Topiramate to Treat Epilepsy, Migraines

Robert Califf, MD, Nominated by Biden Administration as Next FDA Commissioner

Thanks for listening to the NeurologyLive® Mind Moments™ podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

...more

View all episodes

By NeurologyLive

4.6

1010 ratings